Pointe Capital Management LLC Novartis Ag Transaction History

Pointe Capital Management LLC

$171 Million
Q4 2024

A detailed history of Pointe Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Pointe Capital Management LLC holds 3,598 shares of NVS stock, worth $392,361. This represents 0.2% of its overall portfolio holdings.

Number of Shares

3,598

Previous 3,598 -0.0%

Holding current value

$392,361

Previous $350,000 -0.0%

% of portfolio

0.2%

Previous 0.2%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$96.78 - $117.18 $5,419 - $6,562	56 Added 1.58%	3,598 $350,000
Q3 2024 Oct 24, 2024	SELL	$106.13 - $120.89 $31,839 - $36,267	-300 Reduced 7.81%	3,542 $407,000
Q1 2024 May 07, 2024	SELL	$95.27 - $108.47 $33,535 - $38,181	-352 Reduced 8.39%	3,842 $371,000
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $3,967 - $4,366	43 Added 1.04%	4,194 $423,000
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $1,989 - $2,207	21 Added 0.51%	4,151 $422,000
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $5,181 - $5,874	56 Added 1.37%	4,130 $416,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $1,920 - $2,227	-24 Reduced 0.59%	4,074 $374,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $15,110 - $18,504	-200 Reduced 4.65%	4,098 $372,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $4,028 - $4,712	54 Added 1.27%	4,298 $327,000
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $35,729 - $40,416	446 Added 11.74%	4,244 $372,000
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $11,955 - $13,219	150 Added 4.11%	3,798 $332,000
Q3 2021 Oct 29, 2021	BUY	$81.78 - $95.14 $3,271 - $3,805	40 Added 1.11%	3,648 $298,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $10,655 - $11,768	125 Added 3.59%	3,608 $329,000
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $5,511 - $6,499	-66 Reduced 1.86%	3,483 $298,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $11,007 - $13,314	-141 Reduced 3.82%	3,549 $335,000
Q3 2020 Nov 05, 2020	BUY	$82.14 - $91.0 $9,856 - $10,920	120 Added 3.36%	3,690 $321,000
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $18,798 - $26,336	-266 Reduced 6.93%	3,570 $294,000
Q4 2019 Feb 04, 2020	SELL	$84.35 - $95.37 $1,265 - $1,430	-15 Reduced 0.39%	3,836 $363,000
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $2,395 - $2,639	-28 Reduced 0.72%	3,851 $335,000
Q2 2019 Aug 08, 2019	SELL	$75.4 - $92.8 $9,726 - $11,971	-129 Reduced 3.22%	3,879 $354,000
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $5,046 - $5,772	-67 Reduced 1.64%	4,008 $385,000
Q4 2018 Feb 06, 2019	SELL	$73.66 - $82.02 $3,462 - $3,854	-47 Reduced 1.14%	4,075 $350,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $30,792 - $35,617	460 Added 12.56%	4,122 $355,000
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $49,915 - $56,413	769 Added 26.58%	3,662 $277,000
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $3,519 - $4,207	50 Added 1.76%	2,893 $234,000
Q4 2017 Jan 12, 2018	SELL	$72.33 - $77.64 $10,777 - $11,568	-149 Reduced 4.98%	2,843 $239,000
Q3 2017 Oct 16, 2017	BUY	$74.14 - $77.27 $221,826 - $231,191	2,992	2,992 $257,000

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pointe Capital Management LLC with notifications on news.

Account

Pointe Capital Management LLC Novartis Ag Transaction History